Matrix Metalloproteinase 2
"Matrix Metalloproteinase 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
Descriptor ID |
D020778
|
MeSH Number(s) |
D08.811.277.656.300.480.205.352 D08.811.277.656.300.480.252.420 D08.811.277.656.300.480.525.700.150 D08.811.277.656.675.374.205.352 D08.811.277.656.675.374.252.420 D08.811.277.656.675.374.525.700.150
|
Concept/Terms |
Matrix Metalloproteinase 2- Matrix Metalloproteinase 2
- Metalloproteinase 2, Matrix
- 72-kDa Type IV Collagenase
- 72 kDa Type IV Collagenase
- Gelatinase A
- MMP2 Metalloproteinase
- Metalloproteinase, MMP2
- MMP-2 Metalloproteinase
- MMP 2 Metalloproteinase
- Metalloproteinase, MMP-2
- 72-kDa Gelatinase
- 72 kDa Gelatinase
- Gelatinase, 72-kDa
- Matrix Metalloproteinase-2
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 2".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 2".
This graph shows the total number of publications written about "Matrix Metalloproteinase 2" by people in UAMS Profiles by year, and whether "Matrix Metalloproteinase 2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 0 | 1 | 1 | 2020 | 0 | 1 | 1 | 2014 | 1 | 0 | 1 | 2011 | 0 | 1 | 1 | 2009 | 1 | 0 | 1 | 2008 | 0 | 1 | 1 | 2007 | 1 | 4 | 5 | 2006 | 0 | 1 | 1 | 2005 | 2 | 0 | 2 | 2004 | 1 | 0 | 1 | 2002 | 0 | 2 | 2 | 2000 | 2 | 0 | 2 | 1999 | 0 | 2 | 2 | 1998 | 0 | 1 | 1 | 1996 | 0 | 1 | 1 | 1995 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Matrix Metalloproteinase 2" by people in Profiles over the past ten years.
-
Zhao Z, Fetse J, Mamani UF, Guo Y, Li Y, Patel P, Liu Y, Lin CY, Li Y, Mustafa B, Cheng K. Development of a peptide-based tumor-activated checkpoint inhibitor for cancer immunotherapy. Acta Biomater. 2025 01 24; 193:484-497.
-
Fancher K, Gardner JM, Shalin SC. Elastophagocytosis and interstitial granulomatous infiltrate are more common in extragenital vs genital lichen sclerosus. J Cutan Pathol. 2020 Oct; 47(10):903-912.
-
Tripathi R, Singh P, Singh A, Chagtoo M, Khan S, Tiwari S, Agarwal G, Meeran SM, Godbole MM. Zoledronate and Molecular Iodine Cause Synergistic Cell Death in Triple Negative Breast Cancer through Endoplasmic Reticulum Stress. Nutr Cancer. 2016 May-Jun; 68(4):679-88.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|